Last updated on November 2017

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder


Brief description of study

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Detailed Study Description

Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Clinical Study Identifier: TX11117

Contact Investigators or Research Sites near you

Start Over

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA